Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway

被引:22
|
作者
Liu, Xia [1 ]
Peng, Jiamin [2 ]
Zhou, Yayun [2 ]
Xie, Bei [2 ]
Wang, Jianchao [3 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Cent Lab, 318 C haowang Rd, Hangzhou 310005, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou 310005, Zhejiang, Peoples R China
[3] Zhejiang Tongde Hosp Zhejiang Prov, Dept Clin Lab, 234 Gucui Rd, Hangzhou 310012, Zhejiang, Peoples R China
关键词
multiple myeloma; ribonucleotide reductase M2; DNA damage; apoptosis; Wnt/beta-catenin signaling; RIBONUCLEOTIDE REDUCTASE M2; THERAPEUTIC TARGET; RNA INTERFERENCE; CANCER; SUBUNIT; EXPRESSION; CELLS; SUPPRESSION; APOPTOSIS; PROMOTES;
D O I
10.3892/mmr.2019.10465
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ribonucleotide reductase M2 (RRM2) is one of the two subunits that comprise ribonucleotide reductase (RR), the enzyme that catalyzes the conversion of ribonucleotide 5'-diphosphates into 2'-deoxyribonucleotides, which are required for DNA synthesis. RRM2 is a stress response factor important for the development of several tumors. However, its role in multiple myeloma (MM) remains to be fully elucidated. The present study aimed to investigate the role of RRM2 in MM. The expression of RRM2 in patients with MM was analyzed using the Oncomine database. The results demonstrated that RRM2 expression was higher in MM compared with healthy subjects. Reverse transcription-quantitative polymerase chain reaction and western blot results revealed that RRM2 expression was decreased following transfection with a small interfering RNA targeting RRM2 into NCI-H929 cells. RR activity and Cell Counting Kit-8 assays demonstrated that RRM2 silencing reduced RR activity and inhibited cell proliferation. Annexin V-propidium iodide staining indicated that the percentage of apoptotic NCI-H929 cells was increased following RRM2 silencing compared with that in the control group. Increased phosphorylation of H2AX indicated that RRM2 silencing may activate the DNA-damage response pathway in NCI-H929 cells. Western blot analysis revealed that protein levels of the apoptosis-associated factor Bcl-2 were reduced, whereas Bax, cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase 1 were upregulated following RRM2 silencing compared with the control group. In addition, the results demonstrated that RRM2 silencing may inhibit target gene expression in the Wnt/beta-catenin signaling pathway by increasing the phosphorylation of glucose synthase kinase 3 beta. These findings indicated that RRM2 may be involved in the proliferation and apoptosis of MM cells via the Wnt/beta-catenin signaling pathway, suggesting that RRM2 may represent a novel therapeutic target for MM.
引用
收藏
页码:2159 / 2166
页数:8
相关论文
共 50 条
  • [31] MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway
    Si, Wentao
    Li, Yulin
    Shao, Hongmin
    Hu, Rongrong
    Wang, Wen
    Zhang, Kangle
    Yang, Qifeng
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (02): : 191 - 199
  • [32] Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
    Zhang, You
    Zhang, Hongmei
    Yang, Shanshan
    Gao, Xiufeng
    Guo, Wenhao
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2024, 19 (03)
  • [33] BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus
    Ding, Fengxia
    Wang, Meisa
    Du, Yibo
    Du, Shuangshuang
    Zhu, Zhongling
    Yan, Zhao
    SCIENTIFIC REPORTS, 2016, 6
  • [34] Gene Silencing of β-catenin Inhibits Growth of Wnt/β-catenin Pathway Dependent Colon Cancer Cell Lines
    Bujak, A.
    Matloka, M.
    Mazur, M.
    Skupinska, M.
    Lamparska-Przybysz, M.
    Wieczorek, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S253 - S253
  • [35] BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus
    Fengxia Ding
    Meisa Wang
    Yibo Du
    Shuangshuang Du
    Zhongling Zhu
    Zhao Yan
    Scientific Reports, 6
  • [36] Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway
    Niu, Haiying
    Zhou, Wei
    Xu, Yingxi
    Yin, Zhiqi
    Shen, Wenzhi
    Ye, Zhen
    Liu, Yanhua
    Chen, Yanan
    Yang, Shuang
    Xiang, Rong
    Wang, Lina
    Qu, Pengpeng
    ONCOTARGET, 2017, 8 (44) : 76266 - 76278
  • [37] KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway
    Cui, Zhi
    Cui, Ye
    Yang, Shuting
    Luo, Gan
    Wang, Yang
    Lou, Yixin
    Sun, Xinhua
    CELL BIOLOGY INTERNATIONAL, 2017, 41 (04) : 392 - 404
  • [38] GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway
    Ding, Xiang
    Deng, Gang
    Liu, Junhui
    Liu, Baohui
    Yuan, Fan'en
    Yang, Xue
    Chen, Qianxue
    BRAIN RESEARCH, 2019, 1717 : 117 - 126
  • [39] Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
    Yi, Zhigang
    Pu, Yanchuan
    Gou, Ruoyan
    Chen, Yonggang
    Ren, Xiaojun
    Liu, Wenzhong
    Dong, Ping
    MOLECULAR MEDICINE REPORTS, 2020, 21 (03) : 1154 - 1162
  • [40] PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway
    Xu, Yonghui
    Yang, Zesong
    Yuan, Haiting
    Li, Zhen
    Li, Ying
    Liu, Qiong
    Chen, Jianbin
    ONCOLOGY REPORTS, 2015, 34 (02) : 747 - 754